We demonstrate that acetate treatment primes neutrophils in a GPR43-dependent manner leading to enhanced neutrophil chemotaxis, bacterial killing as well as improved resolution of inflammation and sepsis outcome. The gene discussed is FFAR2; the disease is Sepsis.